OpenVSafe by OpenVAERS
Search V-safe

9RN-13045-46802

2 vaccinations 1 coded response 3 check-ins 1 free-text entry 1 call case
Sex
Female
Age at first dose
31-35
ZIP prefix
200 / DC
Registered
2021-06-25
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-06-25
    Registered in v-safe
  2. 2021-06-25
    Dose 1 — Pfizer-BioNTech
  3. 2021-06-25
    Health check-in — day 0, dose 1
    Feeling: Fair · Site: Pain, Swelling · Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  4. 2021-06-27
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  5. 2021-07-16
    Dose 2 — Pfizer-BioNTech
  6. 2021-08-08
    Survey response — day 21, dose 2
    MedDRA: Anosmia, COVID-19, Cough, Headache, Myalgia, Pyrexia, Sinusitis — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Contracted covid 3 weeks after 2nd dose - fever, headache, sinus infection, cough, sore muscles, complete loss of smell
    MedDRA releases: 2021-09,2024-11 · check-in free text available
  7. 2021-08-08
    Report sent to call center — day 21, dose 2
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    1 call case(s)
  8. 2021-08-11
  9. 2021-08-11
    Call successful
    Not applicable (accidental reporting or does not believe symptoms are related to vaccine)

Vaccinations

DoseDateManufacturerCo-administered
12021-06-25Pfizer-BioNTech No
22021-07-16Pfizer-BioNTech No

Call center

1 call center case

1 successful

See the call center timeline

Free text

Release 9 — day 21, dose 2

2021-08-08

Symptoms: Contracted covid 3 weeks after 2nd dose - fever, headache, sinus infection, cough, sore muscles, complete loss of smell

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDAnosmia ✓ · ✓
SDCough ✓ · ✓
SDCOVID-19 ✓ · ✓
SDHeadache ✓ · ✓
SDMyalgia ✓ · ✓
SDPyrexia ✓ · ✓
SDSinusitis ✓ · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release